Mehrotra P, Bear H D, Susskind B M
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Cell Immunol. 1991 Feb;132(2):451-65. doi: 10.1016/0008-8749(91)90042-a.
We have previously reported the selective inhibition of cytotoxic T lymphocytes (CTL) by 10 mM ornithine (ORN) relative to natural killer (NK) cell-derived lymphokine activated killer cells (LAK). To determine if this were due to differences in the progenitor cells or the type of stimulus, we used cortisone-resistant thymocytes (CRT) as a source of mature T cells for induction of LAK and CTL, and compared the results with spleen. Thymic and splenic CTL precursors (CTLp) from C57B1/6 (B6) mice were CD8+, ASGM1-, ORN sensitive. Splenic LAK precursors (LAKp) were CD8-, ASGM1+, ORN resistant when assayed against both YAC-1 and P815 tumor targets. In contrast, CRT-derived LAKp were CD8-, ASGM1+, ORN resistant against YAC-1, whereas LAKp against P815 were CD8+, ASGM1+, ORN sensitive. ORN sensitivity was also observed among CTL and LAK in DBA/2 mice and was associated with CD8+ phenotype. Therefore, our initial observation of differential ORN sensitivity in CTL vs LAK was a function of the progenitor cells; furthermore, CD8+ cytolytic cells are ORN sensitive whether activated by antigen (CTL) or IL-2 (T-LAK).
我们之前曾报道,相对于自然杀伤(NK)细胞衍生的淋巴因子激活的杀伤细胞(LAK),10 mM鸟氨酸(ORN)可选择性抑制细胞毒性T淋巴细胞(CTL)。为了确定这是由于祖细胞的差异还是刺激类型的差异所致,我们使用抗可的松胸腺细胞(CRT)作为成熟T细胞的来源来诱导LAK和CTL,并将结果与脾脏进行比较。来自C57B1/6(B6)小鼠的胸腺和脾脏CTL前体(CTLp)为CD8 +、抗唾液酸糖蛋白1(ASGM1)-、ORN敏感。当针对YAC-1和P815肿瘤靶标进行检测时,脾脏LAK前体(LAKp)为CD8 -、ASGM1 +、ORN抗性。相比之下,CRT衍生的LAKp针对YAC-1为CD8 -、ASGM1 +、ORN抗性,而针对P815的LAKp为CD8 +、ASGM1 +、ORN敏感。在DBA/2小鼠的CTL和LAK中也观察到ORN敏感性,并且与CD8 +表型相关。因此,我们最初观察到的CTL与LAK之间ORN敏感性差异是祖细胞的作用;此外,CD8 +溶细胞性细胞无论被抗原(CTL)还是IL-2(T-LAK)激活,均对ORN敏感。